[go: up one dir, main page]

CL2012001927A1 - Antibody capable of neutralizing the activity of a dabigatran anticoagulant; antibody manufacturing method; kit comprising the antibody. - Google Patents

Antibody capable of neutralizing the activity of a dabigatran anticoagulant; antibody manufacturing method; kit comprising the antibody.

Info

Publication number
CL2012001927A1
CL2012001927A1 CL2012001927A CL2012001927A CL2012001927A1 CL 2012001927 A1 CL2012001927 A1 CL 2012001927A1 CL 2012001927 A CL2012001927 A CL 2012001927A CL 2012001927 A CL2012001927 A CL 2012001927A CL 2012001927 A1 CL2012001927 A1 CL 2012001927A1
Authority
CL
Chile
Prior art keywords
antibody
neutralizing
kit
activity
manufacturing
Prior art date
Application number
CL2012001927A
Other languages
Spanish (es)
Inventor
Ryn Joanne Van
John Edward Park
Norbert Hauel
Ulrich Kunz
Tobias Litzenburger
Keith Canada
Alisa Waterman
Sanjaya Singh
Original Assignee
Boehringer Ingelheim Int Gbmh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int Gbmh filed Critical Boehringer Ingelheim Int Gbmh
Publication of CL2012001927A1 publication Critical patent/CL2012001927A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A MOLÉCULAS DE ANTICUERPO CONTRA ANTICOAGULANTES, EN PARTICULAR DABIGATRÁN, Y SU USO COMO ANTÍDOTOS DE DICHOS ANTICOAGULANTESTHE PRESENT INVENTION REFERS TO ANTIBODY MOLECULES AGAINST ANTICOAGULANTS, IN PARTICULAR DABIGATRAN, AND THEIR USE AS ANTIDOTES OF SUCH ANTICOAGULANTS

CL2012001927A 2010-01-20 2012-07-10 Antibody capable of neutralizing the activity of a dabigatran anticoagulant; antibody manufacturing method; kit comprising the antibody. CL2012001927A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10151239 2010-01-20
US38391410P 2010-09-17 2010-09-17

Publications (1)

Publication Number Publication Date
CL2012001927A1 true CL2012001927A1 (en) 2012-12-14

Family

ID=69650493

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001927A CL2012001927A1 (en) 2010-01-20 2012-07-10 Antibody capable of neutralizing the activity of a dabigatran anticoagulant; antibody manufacturing method; kit comprising the antibody.

Country Status (1)

Country Link
CL (1) CL2012001927A1 (en)

Similar Documents

Publication Publication Date Title
ECSP12012105A (en) Anticoagulant Antidotes
ECSP13012997A (en) Anticoagulant antidotes
DOP2011000084A (en) USE OF DITIINE-TETRACARBOXIMIDES TO COMBAT FITOPATOGEN FUNGI
WO2013177133A3 (en) Generation of human ips cells by a synthetic self- replicative rna
MX353827B (en) Forms of rifaximin and uses thereof.
MX382840B (en) MODIFIED ANTIBODY REGIONS AND THEIR USES.
PE20190229A1 (en) ANTI-FCRN ANTIBODIES
MX2019009789A (en) SELECTION METHODS FOR MICROORGANISMS THAT PROVIDE BENEFICIAL PROPERTIES TO PLANTS.
WO2014028777A3 (en) Methods of treating a tauopathy
BR112013024574A2 (en) polypeptide, use, method of treating individuals with disease, and method of treating individuals having diseases with a polypeptide
WO2012129341A3 (en) Disease detection in plants
AR093446A1 (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
CL2014002911A1 (en) Anti-gcc antibody; Method of production; kit containing it and uses
ECSP14013302A (en) STABLE IODINE-POVIDONA COMPOSITIONS
BR112014031412A2 (en) method of preparing a composition, composition and its use, and kit.
UY34372A (en) NUCLEIC ACID MOLECULES THAT ARE DIRECTED TO RPA70 AND CONFERENCE RESISTANCE TO PATHOPHERAL PESTS.
ECSP13012536A (en) ANTIBODY COMPOSITIONS AND METHODS OF USE
GT201300256A (en) PROCESSES FOR THE DEVELOPMENT OF MACROCYCLIC DEPSIPEPTIDES AND NEW INTERMEDIARIES
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
EA201590503A1 (en) ALPHA-1-Microglobulin for use in the treatment of diseases associated with mitochondria
EA201690856A1 (en) APPLICATION OF FATTY ACID OF TALL OIL IN CONNECTING TOXINS
WO2012145399A3 (en) Methods of diagnosing cancer in a patient
CL2014003480A1 (en) Use of astigmatid mite eggs as a source of nutrients for a population of arthropod biological control agents; biological control composition comprising the control agents and the source of nutrients; and method to raise arthropods.
WO2014059326A3 (en) Methods of identifying compounds for treating depression and other related diseases
CL2012001927A1 (en) Antibody capable of neutralizing the activity of a dabigatran anticoagulant; antibody manufacturing method; kit comprising the antibody.